GAPDH Rabbit Polyclonal Conjugated Antibody
Referentie MBS9448410-0,1mL-AF405
Formaat : 0.1mL(AF405)
Merk : MyBiosource
GAPDH Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9448410Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) is well known as one of the key enzymes involved in glycolysis. GAPDH is constitutively expressed in almost all tissues at high levels, therefore antibodies against GAPDH are useful as loading controls for… More details
Product Overview
Product Name
GAPDH, Polyclonal Antibody
Full Product Name
GAPDH Rabbit Polyclonal Conjugated Antibody
Product Gene Name
anti-GAPDH antibody
Product Synonym Names
G3PD; GAPD; MGC88685
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Rat, Mouse, Monkey, Chicken, Hamster, Sheep, Xenopus
Form/Format
0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6, 5mg/ml Bovine Serum Albumin, 0.02% Sodium Azide
Specificity
antibody detects endogenous GAPDH protein.
Preparation and Storage
Store at 4 degree C for 6 months.
Applications Tested/Suitable for anti-GAPDH antibody
Most Applications
Application Notes for anti-GAPDH antibody
Suggested Dilution:
AF350 conjugated: most applications: 1:50-1:250
AF405 conjugated: most applications: 1:50-1:250
AF488 conjugated: most applications: 1:50-1:250
AF555 conjugated: most applications: 1:50-1:250
AF594 conjugated: most applications: 1:50-1:250
AF647 conjugated: most applications: 1:50-1:250
AF680 conjugated: most applications: 1:50-1:250
AF750 conjugated: most applications: 1:50-1:250
Biotin conjugated: working with enzyme-conjugated streptavidin, most applications: 1:50-1:1000
AF350 conjugated: most applications: 1:50-1:250
AF405 conjugated: most applications: 1:50-1:250
AF488 conjugated: most applications: 1:50-1:250
AF555 conjugated: most applications: 1:50-1:250
AF594 conjugated: most applications: 1:50-1:250
AF647 conjugated: most applications: 1:50-1:250
AF680 conjugated: most applications: 1:50-1:250
AF750 conjugated: most applications: 1:50-1:250
Biotin conjugated: working with enzyme-conjugated streptavidin, most applications: 1:50-1:1000
Other Notes
Small volumes of anti-GAPDH antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for GAPDH purchase
MBS9448410 is an antibody targeting GAPDH. Also known as GAPDH Rabbit Polyclonal Conjugated Antibody. Reactive in Human, Rat, Mouse, Monkey, Chicken, Hamster, Sheep, Xenopus. Host: Rabbit.
Additional Details
NCBI/Uniprot data below describe general gene information for GAPDH. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
glyceraldehyde-3-phosphate dehydrogenase isoform 2
NCBI Official Synonym Full Names
glyceraldehyde-3-phosphate dehydrogenase
NCBI Official Symbol
GAPDH
NCBI Official Synonym Symbols
G3PD; GAPD
UniProt Protein Name
Glyceraldehyde-3-phosphate dehydrogenase
UniProt Synonym Protein Names
Peptidyl-cysteine S-nitrosylase GAPDH
Protein Family
Glyceraldehyde-3-phosphate dehydrogenase
UniProt Gene Name
GAPDH
UniProt Synonym Gene Names
GAPD; GAPDH
UniProt Entry Name
G3P_HUMAN
NCBI Protein Information
glyceraldehyde-3-phosphate dehydrogenase; aging-associated gene 9 protein; peptidyl-cysteine S-nitrosylase GAPDH
NCBI Summary for GAPDH
The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains. Many pseudogenes similar to this locus are present in the human genome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
Show more UniProt Comments for GAPDH
GAPDH: a multifunctional enzyme with both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities. A key glycolytic enzyme that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate. An important enzyme for energy metabolism, and the production of ATP and pyruvate through anaerobic glycolysis in the cytoplasm. Additionally, it participates in apoptosis, membrane trafficking, iron metabolism, nuclear activities and receptor mediated cell signaling. Its subcellular localization changes reflecting its multiple activities. Is cytosolic, but is also localized in the membrane, the nucleus, polysomes, the ER and the Golgi. Participates in transcription, RNA transport, DNA replication and apoptosis. S-nitrosylation on Cys-152 following apoptotic stimulates its interaction with SIAH2, which in turn moderates its translocation into the nucleus. Mediates cysteine S-nitrosylation of nuclear target proteins including SIRT1, HDAC2 and DNA-PK. Deregulated in lung cancer, renal cancer, breast cancer, gastric cancer, glioma, liver cancer, colorectal cancer, melanoma, prostatic cancer, pancreatic cancer and bladder cancer. Its increased expression and enzymatic activity is associated with cell proliferation and tumorigenesis, Oxidative stress impairs GAPDH catalytic activity and leads to cellular aging and apoptosis. In experimental animal models, injection of GAPDH antagonists induces apoptosis and blocks Hep3B tumor progression, suggesting a therapeutic potential of targeting GAPDH in human hepatocellular carcinoma
Protein type: Carbohydrate Metabolism - glycolysis and gluconeogenesis; Oxidoreductase; EC 1.2.1.12
Chromosomal Location of Human Ortholog: 12p13
Cellular Component: microtubule cytoskeleton; nuclear membrane; membrane; intracellular membrane-bound organelle; perinuclear region of cytoplasm; cytoplasm; plasma membrane; lipid particle; ribonucleoprotein complex; cytosol; nucleus; vesicle
Molecular Function: identical protein binding; protein binding; microtubule binding; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; NADP binding; NAD binding
Biological Process: neuron apoptosis; glycolysis; protein stabilization; negative regulation of translation; carbohydrate metabolic process; glucose metabolic process; pathogenesis; microtubule cytoskeleton organization and biogenesis; gluconeogenesis
Show more Protein type: Carbohydrate Metabolism - glycolysis and gluconeogenesis; Oxidoreductase; EC 1.2.1.12
Chromosomal Location of Human Ortholog: 12p13
Cellular Component: microtubule cytoskeleton; nuclear membrane; membrane; intracellular membrane-bound organelle; perinuclear region of cytoplasm; cytoplasm; plasma membrane; lipid particle; ribonucleoprotein complex; cytosol; nucleus; vesicle
Molecular Function: identical protein binding; protein binding; microtubule binding; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; NADP binding; NAD binding
Biological Process: neuron apoptosis; glycolysis; protein stabilization; negative regulation of translation; carbohydrate metabolic process; glucose metabolic process; pathogenesis; microtubule cytoskeleton organization and biogenesis; gluconeogenesis
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-GAPDH antibody
| Reference Product | PubMed Publications |
|---|---|
| ACTB antibody | >162 publications with GAPDH and ACTB |
| PGK1 antibody | >35 publications with GAPDH and PGK1 |
| SIAH1 antibody | >13 publications with GAPDH and SIAH1 |
| APP antibody | >10 publications with GAPDH and APP |
| EGFR antibody | >8 publications with GAPDH and EGFR |
| SLC2A1 antibody | >7 publications with GAPDH and SLC2A1 |
| HTT antibody | >6 publications with GAPDH and HTT |
| SLC2A4 antibody | >3 publications with GAPDH and SLC2A4 |
| S100A6 antibody | >2 publications with GAPDH and S100A6 |
| LAMA4 antibody | >1 publications with GAPDH and LAMA4 |
Pathways associated with anti-GAPDH antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Alzheimer's Disease Pathway antibodies | Alzheimer's Disease Pathway Diagram |
| Alzheimer's Disease Pathway antibodies | Alzheimer's Disease Pathway Diagram |
| Alzheimers Disease Pathway antibodies | Alzheimers Disease Pathway Diagram |
| Biosynthesis Of Amino Acids Pathway antibodies | Biosynthesis Of Amino Acids Pathway Diagram |
| Biosynthesis Of Amino Acids Pathway antibodies | Biosynthesis Of Amino Acids Pathway Diagram |
| Gluconeogenesis Pathway antibodies | Gluconeogenesis Pathway Diagram |
| Gluconeogenesis, Oxaloacetate => Fructose-6P Pathway antibodies | Gluconeogenesis, Oxaloacetate => Fructose-6P Pathway Diagram |
| Gluconeogenesis, Oxaloacetate => Fructose-6P Pathway antibodies | Gluconeogenesis, Oxaloacetate => Fructose-6P Pathway Diagram |
| Glucose Metabolism Pathway antibodies | Glucose Metabolism Pathway Diagram |
| Glycolysis Pathway antibodies | Glycolysis Pathway Diagram |
Diseases associated with anti-GAPDH antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >575 publications with GAPDH and Neoplasms |
| Nervous System Diseases Antibodies | >228 publications with GAPDH and Nervous System Diseases |
| Cardiovascular Diseases Antibodies | >209 publications with GAPDH and Cardiovascular Diseases |
| Brain Diseases Antibodies | >175 publications with GAPDH and Brain Diseases |
| Necrosis Antibodies | >140 publications with GAPDH and Necrosis |
| Inflammation Antibodies | >130 publications with GAPDH and Inflammation |
| Heart Diseases Antibodies | >125 publications with GAPDH and Heart Diseases |
| Drug Toxicity Antibodies | >121 publications with GAPDH and Drug Toxicity |
| Liver Diseases Antibodies | >104 publications with GAPDH and Liver Diseases |
| Kidney Diseases Antibodies | >83 publications with GAPDH and Kidney Diseases |
Organs/Tissues associated with anti-GAPDH antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >676 publications with GAPDH and Blood |
| Muscle Antibodies | >456 publications with GAPDH and Muscle |
| Brain Antibodies | >403 publications with GAPDH and Brain |
| Liver Antibodies | >314 publications with GAPDH and Liver |
| Heart Antibodies | >244 publications with GAPDH and Heart |
| Vascular Antibodies | >229 publications with GAPDH and Vascular |
| Kidney Antibodies | >207 publications with GAPDH and Kidney |
| Lung Antibodies | >180 publications with GAPDH and Lung |
| Bone Antibodies | >148 publications with GAPDH and Bone |
| Nerve Antibodies | >108 publications with GAPDH and Nerve |


